Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit

Yakugaku Zasshi

Volumn 131, Issue 4, 2011, Pages 563-570

  Imaura, Masaharu ^a,b   Kohata, Yuji ^a   Kobayashi, Koutarou ^a   Takahashi, Hiroyuki ^a   Yokoyama, Haruko ^b   Akase, Tomohide ^a   Yamada, Yasuhiko ^b  

^a SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Duration of antibiotic therapy; Intensive care unit; Intervention; Medical cost; Methicillin resistant Staphylococcus aureus; Pharmaceutical care

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE REGIMEN; HUMAN; INTENSIVE CARE UNIT; INTERVENTION STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PHARMACIST; PROGNOSIS; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; WARD;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; ECONOMICS, PHARMACEUTICAL; FEMALE; HEALTH CARE COSTS; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PATIENT CARE TEAM; PHARMACISTS; PNEUMONIA, STAPHYLOCOCCAL; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 79953715395     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.131.563     Document Type: Article

References (20)

1. Kitamura M., Kawai T., Kikuno F., Jpn. J. Pharm. Health Care Sci., 29, 485-490 (2003).
2. Shiraishi T., Biomedicine & Therapeutics, 40, 134-136 (2006).
3. Hori K., J. Practical Pharmacy, 56, 3093-3099 (2005).
4. Dellit T. H., Owens R. C., McGowan J. E. Jr., Gerding D. N., Weinstein R. A., Burke J. P., Huskins W. C., Paterson D. L., Fishman N. O., Carpenter C. F., Brennan P. J., Billeter M., Hooton T. M., Clin. Infect. Dis., 44, 159-177 (2007).
5. Tanaka A., Suemaru K., Moriguchi T., Araki H., J. Jpn. Soc. Hosp. Pharm., 42, 759-761 (2006).
6. Okuda T., Asonuma K., Itano M., Takao M., Kimura M., J. Jpn. Soc. Hosp. Pharm., 40, 1153-1156 (2004).
7. Funakoshi S., Yamasaki M., Yamato H., Nakamura M., Kugaya Y., Ohno S., Watanabe Y., Kiribayashi Y., Jpn. J. Pharm. Health Care Sci., 33, 571-577 (2007).
8. Morita K., Tanigawara Y., Antibiot. Chemother., 20, 1158-1163 (2004).
9. The Japanese Association for Infectious Diseases: 〈http://www.kansensho.or.jp/topics/pdf/mrsa_tebiki.pdf〉, cited 13 August, 2010.
10. Winter M. E., "Basic Clinical Pharmacokinetics 4th Edition," eds. by Shinozaki K., Hiraoka K., Kawasaki M., Technomics, Inc., Tokyo, 2005, pp. 419-423.
11. SHIONOGI-VCM-TDM S_edition ver.1.03.
12. "The JRS Guidelines for the Management of Hospital-acquired Pneumonia in Adults," ed. by the Committee for the JRS Guidelines in Management of Respiratory Infections, The Japanese Respiratory Society, 2008.
13. Kumar A., Roberts D., Wood K. E., Light B., Parrillo J. E., Sharma S., Suppes R., Feinstein D., Zanotti S., Taiberg L., Gurka D., Kumar A., Cheang M., Crit. Care Med., 34, 1589-1596 (2006).
14. Ibrahim E. H., Sherman G., Ward S., Fraser V. J., Kollef M. H., Chest, 118, 146-155 (2000).
15. Japan Nosocominal Infections Surveillance: 〈http://www.nih-janis.jp/report/season/nenpou/2006/zen02.html〉, cited 13 August, 2010.
16. Ishizaka T., Mukai J., Fukushima M., Takahashi N., Asaka K., J. Jpn. Soc. Hosp. Pharm., 40, 1125-1128 (2004).
17. Itoh H., Sato Y., Katagiri F., Otsuka M., Inoue S., Arao K., Takeyama M., J. Jpn. Soc. Hosp. Pharm., 43, 1669-1672 (2007).
18. Oishi Y., Otake H., J. Jpn. Soc. Hosp. Pharm., 44, 1383-1385 (2008).
19. Tanigawara Y., J. Jpn. Medical Association, 135, S390-S393 (2006).
20. Rybak M., Lomaestro B., Rotschafer J. C., Moellering R. Jr., Craig W., Billeter M., Dalovisio J. R., Levine D. P., Am. J. Health Syst. Pharm., 66, 82-98 (2009).